Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1996-06-07
1998-12-01
Elliott, George C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
435 914, 4353201, A61K 3170, C12N 1564, C12N 1585
Patent
active
058439137
ABSTRACT:
Vectors containing a nucleotide sequence coding for an F protein of respiratory syncytial virus (RSV) and a promoter for such sequence, preferably a cytomegalovirus promoter, are described. Such vectors also may contain a further nucleotide sequence located adjacent to the RSV F protein encoding sequence to enhance the immunoprotective ability of the RSV F protein when expressed in vivo. Such vectors may be used to immunize a host, including a human host, by administration thereto. Such vectors also may be used to produce antibodies for detection of RSV infection in a sample.
REFERENCES:
patent: 5589466 (1996-12-01), Felgner et al.
Chanock--Pediatrics vol. 90, No. 1, Jul. 1992, pp. 137-142.
Groothuis et al-N. Engl. J. Med. 329:1524.
Paradiso et al, Pediatr. Infect. Dis. J. 13; 792.
Prince et al-J. Virol. 55:517; Virus Res. 3:193.
Walsh et al, J. Infec. Dis. 155; 1198.
Lounsbach, G.R. et al, Journal of General Virology (1993), 74, pp. 2559-2565.
Wertz et al. (1987) Expression of the fusion protein of human respiratory syncytial virus from recombinant vaccinia virus vectors and protection of vaccinated mice. J. Virol. 61:293-301. Feb. 1987.
Wathen et al. (1989) Immunization of cotton rats with the human respiratory syncytial virus F glycoprotein produced using a baculovirus vector. J. Infect. Dis. 159:255-264. Feb. 1989.
Collis et al. (1990) Definition of the minimal requirements within the human beta-globin gene and the dominant control region for high level expression. EMBO J. 9:233-240. Jan. 1990.
Tang et al. (1993) High-level and erythroid-specific expression of human glucose-6-phosphate dehydrogenase in transgenic mice. J. Biol. Chem. 268:9522-9525. May 1993.
Ewasyshyn Mary E.
Klein Michel H.
Li Xiaomao
Sambhara Suryaprakash
Connaught Laboratories Limited
Elliott George C.
Schwartzman Robert
LandOfFree
Nucleic acid respiratory syncytial virus vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acid respiratory syncytial virus vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid respiratory syncytial virus vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2395707